114 Results for "

VC

" in MedChemExpress (MCE) Product Catalog:
Products (114)

114 Results for "VC" in MCE Product Catalog:

103
103 Publications Verification
製品番号: HY-15575
CAS 番号: 646502-53-6
純度:  99.94%
別名: MC-Val-Cit-PAB-MMAE; mc-VC-PAB-MMAE; Vedotin
VcMMAE (mc-vc-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
loading...
    loading...
9
9 Cited Publications
製品番号: HY-W015370
CAS 番号: 39665-12-8
L-Lysine hydrate is an essential amino acid. L-Lysine hydrate can be research for vascular calcification (VC) and acute pancreatitis .
loading...
    loading...
9
9 Cited Publications
製品番号: HY-W014606
CAS 番号: 57282-49-2
L-Lysine acetate is an essential amino acid. L-Lysine acetate can be research for vascular calcification (VC) and Acute pancreatitis .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-112786
CAS 番号: 863971-17-9
純度:  98.16%
別名: VC-MMAF
研究分野:  

Cancer

MC-Val-Cit-PAB-MMAF (Vc-MMAF) is a drug-linker conjugate for ADC by using the tubulin inhibitor, MMAF (HY-15579), linked via cathepsin cleavable MC-Val-Cit-PAB (HY-78738). MC-Val-Cit-PAB-MMAF shows antitumor activity .
loading...
    loading...
4
4 Cited Publications
製品番号: HY-100874
CAS 番号: 3046395-46-1
純度:  98.56%
研究分野:  

Cancer

N3-PEG3-vc-PAB-MMAE is a synthesized agent-linker conjugate for ADC that incorporates the MMAE (a tubulin inhibitor ) and 3-unit PEG linker. N3-PEG3-vc-PAB-MMAE shows potent antitumor activity. N3-PEG3-vc-PAB-MMAE is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
4
4 Cited Publications
製品番号: HY-126682
CAS 番号: 1464051-44-2
純度:  99.41%
研究分野:  

Cancer

Mal-VC-PAB-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker Mal-VC-PAB .
loading...
    loading...
3
3 Cited Publications
製品番号: HY-111012
CAS 番号: 2754384-60-4
純度:  99.60%
研究分野:  

Cancer

DBCO-(PEG)3-VC-PAB-MMAE is a agent-linker conjugate for ADC. DBCO-(PEG)3-VC-PAB-MMAE is made by Monomethyl auristatin E (HY-15162) conjugats to DBCO-(PEG)3-vc-PAB linker. DBCO-(PEG)3-VC-PAB-MMAE can be used for the research of cancer . DBCO-(PEG)3-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
製品番号: HY-136314
CAS 番号: 2129164-91-4
純度:  99.18%
研究分野:  

Cancer

DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in the synthesis of antibody-agent conjugates (ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. DBCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
製品番号: HY-131057
CAS 番号: 1801838-28-7
純度:  96.38%
研究分野:  

Cancer

Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-128957
CAS 番号: 1345681-58-4
純度:  99.95%
別名: Duocarmazine
研究分野:  

Cancer

Vc-seco-DUBA (Duocarmazine) is a agent-linker conjugate for ADC with potent antitumor activity by using DUBA (DNA alkylating agent), linked via the ADC linker Vc-seco .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-126687
CAS 番号: 2259318-52-8
純度:  95.97%
研究分野:  

Cancer

Mal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC, consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU-159682 .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-126681
CAS 番号: 2259318-46-0
純度:  98.01%
別名: NHS-VC-PAB-MMAE
研究分野:  

Cancer

SC-VC-PAB-MMAE (NHS-VC-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-128955
CAS 番号: 1438849-92-3
純度:  99.66%
研究分野:  

Cancer

MC-VC-PABC-Aur0101 is a agent-linker conjugate for ADC with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the ADC linker MC-VC-PABC.
loading...
    loading...
2
2 Cited Publications
製品番号: HY-141604
CAS 番号: 1182215-65-1
純度:  99.90%
別名: CDX-011; CR011-VCMMAE
Glembatumumab vedotin (CDX-011) is an ADC comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-131056
CAS 番号: 2684216-48-4
純度:  99.63%
研究分野:  

Cancer

Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-153739
CAS 番号: 2757277-32-8
純度:  99.95%
研究分野:  

Cancer

N3-PEG3-VC-PAB-MMAF (Comp T-88-5) is a drug-linker conjugate containing the ADC linker N3-PEG3-VC-PAB and the tubulin inhibitor MMAF . N3-PEG3-VC-PAB-MMAF is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
製品番号: HY-148057
CAS 番号: 2758671-45-1
純度:  99.30%
研究分野:  

Cancer

TCO-PEG4-VC-PAB-MMAE is a agent-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE (HY-15162) . TCO-PEG4-VC-PAB-MMAE is a click chemistry reagent, it contains a TCO group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing Tetrazine groups.
loading...
    loading...
製品番号: HY-164239
CAS 番号: 2641442-97-7
別名: NH2-PEG3-VC-PAB-MMAE
LND1002 (NH2-PEG3-VC-PAB-MMAE) is a drug-linker conjugate for ADC. LND1002 is composed of Monomethyl auristatin E (HY-15162) and NH2-PEG3-VC-PAB (HY-189687). LND1002 releases its payload to disrupt microtubules. LND1002 can be used in ADC synthesis-related research, such as CRB‑701 .
loading...
    loading...
製品番号: HY-145448
CAS 番号: 2722697-82-5
純度:  99.93%
研究分野:  

Cancer

MC-VC-PABC-amide-PEG1-CH2-CC-885 (compound I-1) is a neoDegrader-Linker conjugate, consists of the GSPT1 degrader/molecular glue CC-885 (HY-101488) and a linker. MC-VC-PABC-amide-PEG1-CH2-CC-885 can be conjugated to the antibody DAR3.7 that specifically targets CD56 to synthesize Antibody-Drug Conjugates (ADCs) .
loading...
    loading...